Cardinal Health, Inc. (CAH) Stock Analysis

Company Overview

Cardinal Health, Inc. functions as a comprehensive healthcare services and products entity operating across the United States and international markets, delivering customized solutions to hospitals and healthcare providers. The company operates within the Healthcare sector, specifically the Medical Distribution industry, a position that defines its role as a critical intermediary in the supply chain for medical supplies and pharmaceuticals. Cardinal Health manages a substantial operational scale, evidenced by a market capitalization of $48.61B and annual revenue reaching $244.67B, supported by an employee base of 53,084 individuals. These valuation and revenue figures indicate that the company commands a significant position in the global market, reflecting its extensive reach and the essential nature of its distribution services within the healthcare infrastructure.

Financial Health

The company reports trailing twelve-month revenue of $244.67B, with corresponding net income of $1.66B and EBITDA of $3.82B. The substantial gap between the $244.67B in revenue and the $1.66B in net income highlights a highly leveraged cost structure typical of distribution businesses, where operating expenses such as logistics and procurement costs consume the majority of gross receipts before reaching the bottom line. Financial flexibility is supported by free cash flow of $5.44B, which provides the liquidity necessary to service obligations, fund operations, and potentially return capital to stakeholders without relying on external financing. The company maintains a cash balance of $2.78B against total debt of $9.03B, indicating a balance sheet that carries significant leverage relative to its cash reserves, though the specific debt-to-equity ratio is not disclosed in current metrics. Short-term liquidity is assessed via a current ratio of 0.91, which suggests that current assets are slightly lower than current liabilities, implying a need for careful working capital management to meet immediate obligations. Return on Equity is unavailable for calculation, while Return on Assets stands at 3.5%, a metric that reveals the efficiency of management in generating profits from the total asset base, albeit at a relatively modest rate given the scale of operations.

Valuation Assessment

Valuation metrics show a Trailing P/E ratio of 29.77 compared to a Forward P/E of 17.84, implying that the market expects a significant compression in valuation multiples or a sharp increase in future earnings to justify the current stock price. The Price to Book ratio is recorded at -16.91, a figure that indicates the market values the company significantly below its book value, a common characteristic for capital-intensive or debt-heavy entities where book value may not reflect enterprise value accurately. Alternative valuation perspectives include a Price to Sales ratio of 0.20 and an EV/EBITDA of 14.40, suggesting that the company trades at a fraction of its sales revenue but commands a premium multiple on earnings before interest, taxes, depreciation, and amortization relative to peers. Price action over the last year has oscillated between a 52-Week High of $233.60 and a 52-Week Low of $120.72, providing a historical context for current pricing volatility. The stock exhibits a Beta of 0.62, which indicates that price movements are less volatile than the broader market, suggesting a defensive characteristic often found in healthcare distribution utilities.

Growth & Income

Revenue growth for the trailing twelve months is reported at 18.8%, while earnings growth is recorded at 19.4%, indicating that profitability is expanding at a slightly faster pace than top-line sales. This divergence suggests improved operational leverage or margin expansion, although the absolute net income remains small relative to the massive revenue base. As a dividend payer, the company offers a Dividend Yield of 1.0% with a Payout Ratio of 29.3%, a low payout level that implies high sustainability given the company's earnings generation and cash flow profile. The low payout ratio allows the company to retain most of its earnings for reinvestment in operations or debt reduction rather than distributing them entirely. The overall profile combines moderate income generation through dividends with consistent single-digit to low double-digit growth rates in both revenue and earnings.